This announcement is a separate document:
健康元药业集团股份有限公司关于TG-1000胶囊Ⅲ期临床试验达到主要终点的公告
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on reaching the main end of the TG-1000 capsule phase III clinical trial
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.